Eric Campeau
Company: Thryv Therapeutics
Job title: Vice President Translational Research
Seminars:
TRACK B: Translation & Clinical Development 11:00 am
day: Day Two Track B AM
Roundtable Discussion: Improving the Oral Bioavailability of RAS-Targeting Inhibitors to Maintain Coverage of the Target & Increase the Depth of Treatment 12:15 pm
• What is the significance of oral bioavailability for RAS-targeting inhibitors versus other administration routes? • How to design and conduct pre-clinical studies to assess the oral bioavailability and PK/PDRead more
day: Day One Track B AM
TRACK B: Translation & Clinical Development 11:00 am
day: Day One Track B AM